Cargando…
Prognostic factors related to dendritic cell vaccines on patients with advanced non-small cell lung cancers: a multicenter analysis
Autores principales: | Takahashi, Hidenori, Shimodaira, Shigetaka, Ogasawara, Masahiro, Kobayashi, Masanori, Abe, Hirofumi, Nagai, Kazuhiro, Tsujitani, Sunichi, Okamoto, Masato, Morita, Yuji, Yonemitsu, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652538/ http://dx.doi.org/10.1186/2051-1426-3-S2-P451 |
Ejemplares similares
-
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
por: Kobayashi, Masanori, et al.
Publicado: (2014) -
Therapeutic effect of intratumoral injections of dendritic cells for locally recurrent gastric cancer: a case report
por: Kobayashi, Masanori, et al.
Publicado: (2014) -
An optimized cocktail of small molecule inhibitors promotes the maturation of dendritic cells in GM-CSF mouse bone marrow culture
por: Matsuba, Shintaro, et al.
Publicado: (2023) -
Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells
por: Harada, Yui, et al.
Publicado: (2011) -
Mass-production of human dendritic cells in accordance with gmp for clinical studies
por: Harada, Yui, et al.
Publicado: (2015)